Biapenem American Cyanamid Co.
Biapenem is an injectable carbapenem antibiotic with activity against a broad spectrum of bacteria [155679]. It has been submitted for marketing approval in Japan by Lederle Japan, a joint venture between Cyanamid and Takeda. Biapenem is in phase III trials in Germany, South Africa, Spain, Australia and New Zealand for skin infections, and phase I trials in the UK and the US.
Dax
S L
SL
R W Johnson Pharmaceutical Research Institute, Welsh and McKean Roads, R-439, Spring House, PA 19477-0776, USA. SDax@prius.jnj.com